GlassScriptPhysician profile
Millicent E Stettler
NPI 1609452986
$2,019.74
in general payments reported to CMS, 2019-2025
21 companies · $1,318 in 2025
The $1,318 reported for 2025 was more than what 89% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $702 · 2025: $1,318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,020.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,019.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $320.56 | 2024-2025 | Dexcom G6 Transmitter, Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Pfizer INC. | $244.81 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $201.85 | 2024-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $194.84 | 2024-2025 | Breztri, Airsupra |
| Lilly USA, LLC | $186.28 | 2024-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $168.72 | 2024-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $103.23 | 2025 | Trelegy Ellipta, Shingrix |
| Phathom Pharmaceuticals, INC. | $99.85 | 2024 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $89.30 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $74.51 | 2024 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.96 | 2024-2025 | Jardiance, Synjardy |
| Exact Sciences Corporation | $43.51 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amgen INC. | $42.03 | 2024 | Evenity, Prolia |
| Abbvie INC. | $38.47 | 2024-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $35.72 | 2025 | Caplyta |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $31.78 | 2025 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Janssen Pharmaceuticals, INC | $25.99 | 2025 | Spravato |
| Hologic Sales and Service, LLC | $21.65 | 2025 | Aptima |
| Sumitomo Pharma America, INC. | $18.11 | 2025 | Gemtesa |
| Merck Sharp & Dohme LLC | $17.78 | 2024 | Verquvo |
| Kowa Pharmaceuticals America, INC. | $15.79 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Millicent Stettler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.